Century Therapeutics, Inc. (IPSC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 19.57%. A quarter ago, it was expected that this company would post a loss of $0.50 per share when it actually produced a loss of $0.38, delivering a surprise of 24%.Over the last four quarters, the company has ...